Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: A cohort study - 19/08/22
Doi : 10.1016/j.jaad.2021.11.025
Morgan Birabaharan, MD a, ⁎ 
, David C. Kaelber, MD, PhD, MPH b, c, Maile Y. Karris, MD a
, David C. Kaelber, MD, PhD, MPH b, c, Maile Y. Karris, MD a a Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, California
b Departments of Internal Medicine, Pediatrics, and Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, Ohio
c Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland, Ohio
∗Reprint requests: Morgan Birabaharan, MD, Division of Infectious Diseases and Global Public Health, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093Division of Infectious Diseases and Global Public HealthUniversity of California, San Diego9500 Gilman DriveLa JollaCA92093
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
| Funding sources: This work was supported by grants from the NIH (San Diego Center for AIDS Research, CFAR, AI036214). Funders had no role in the design and conduct of study; collection, management, analysis, and interpretation of the datal preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. |
|
| IRB approval status: All data is deidentified and provided in aggregate, no protected health information or personal data are available to users. |
© 2021
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 87 - N° 3
P. 649-651 - septembre 2022 Retour au numéro
Article précédent
- The association between COVID-19 lockdowns and melanoma diagnosis and thickness: A multicenter retrospective study from Europe
- Camila Scharf, Gabriella Brancaccio, Alessandro Di Stefani, Maria Concetta Fargnoli, Harald Kittler, Athanassios Kyrgidis, Aimilios Lallas, Caterina Longo, Josep Malvehy, Elvira Moscarella, Ketty Peris, Simonetta Piana, Susana. Puig, Luc Thomas, Giuseppe Argenziano
- Histologic subtype of cutaneous immune-related adverse events predicts overall survival in patients receiving immune checkpoint inhibitors
- Kelsey E. Hirotsu, Madeleine K.D. Scott, Cesar Marquez, Anhthy T. Tran, Kerri E. Rieger, Roberto A. Novoa, William H. Robinson, Bernice Y. Kwong, Lisa C. Zaba
Bienvenue sur EM-consulte, la référence des professionnels de santé.